In series:OECD Health Policy Studiesview more titles
Published on October 30, 2013
|English||Cancer Care (Summary in English)|
|Spanish||Cancer Care (Summary in Spanish)|
|German||Cancer Care (Summary in German)|
|Japanese||Cancer Care (Summary in Japanese)|
|Italian||Cancer Care (Summary in Italian)|
|Acronyms and abbreviations|
|Cancer care systems: Increasing burdens and existing performance gaps|
|Resources for cancer care|
|Cancer care practice|
|Governance of cancer care systems|
|Exploratory quantitative analysis|
|List of experts on cancer care systems|
>> Breast Cancer Awareness Month, October 2017: Read the article "How should the EU act differently in tackling the burden of breast cancer?", by Francesca Colombo and Rie Fujisawa, Government Gazette, July 2017 issue.
Cancer is one of the major public health issues in OECD countries. It is the second cause of death (after cardiovascular disease), accounting for more than a quarter of all deaths in many OECD countries, while at least one-third of cancer can be prevented and a further third can be either detected early or effectively treated. The OECD collects the following indicators on cancer care: Cancer survival estimates (breast, cervical and colorectal cancers), Cancer mortality rates (all and by type of cancer), and Screening rates (breast and cervical cancers).
Health at a Glance 2019: OECD Indicators includes cross-national data, descriptive analysis and methodological information including definitions for these indicators.
Access the chart set and information about the online database OECD Health Statistics.
The OECD has also undertaken a cross-national analysis of the quality of cancer care performance and published the report below. The analytical work involved the OECD network of national cancer experts and collaboration with key organisations and projects with international expertise in this area, including the CONCORD study which undertakes a study involving an international comparison of survival estimates and the EUROCARE study which follows the survival of cancer patients in Europe.
This report received financial assistance from the European Union
Country KEY FINDINGs
Follow us on Twitter via @OECD_Social